全球肌醇市場:各形狀(膠囊、片劑、粉末)、用途(營養補充品、飲料、醫藥品)、地區(2018年∼2023年)

全球肌醇市場，預計從2018年到2023年的預測期間內以7.8％的年複合成長率發展。多囊性卵巢症候群(PCOS)及糖尿病患者的增加，垃圾食品的消費量增加，不健康的生活習慣等成為這個市場的主要成長要素。

本報告提供全球肌醇市場調查，市場概要，各形狀、用途、地區的市場規模的變化與預測，市場趨勢，市場成長要素及阻礙因素分析，市場機會，競爭情形，主要企業的簡介等全面性資訊。

目錄

第1章 簡介

• 調查階段
• 調查成果
• 市場範圍

第2章 市場洞察

• 市場概要
• 市場趨勢
• 波特的五力分析
  • 買方議價能力
  • 供給企業談判力
  • 新加入業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係

第3章 市場動態

• 市場成長要素
  • 健康飲料的營養成分的肌醇的利用擴大
  • 治療女性的多囊性卵巢症候群(PCOS)的肌醇利用增加
• 市場阻礙因素
  • 生產肌醇對天然成分的依賴
• 市場機會
  • 肌醇的使用法和比優點相關深的認識

第4章 全球肌醇市場:各市場區隔

• 各用途
  • 營養補充品
  • 飲料
  • 醫藥品
  • 其他
• 各形狀
  • 膠囊
  • 平板電腦
  • 粉末
  • 其他

第5章 全球肌醇市場分析:各地區

• 北美
  • 美國
  • 墨西哥
  • 加拿大
  • 其他
• 歐洲
  • 英國
  • 法國
  • 德國
  • 義大利
  • 其他
• 亞太地區
  • 印度
  • 中國
  • 日本
  • 澳洲
  • 其他
• 南美
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他
• 中東、非洲
  • 南非
  • 沙烏地阿拉伯
  • 其他

第6章 競爭情形

• 最積極的企業
• 最常採用的策略
• 市場佔有率分析

第7章 企業簡介

• AstaReal Holdings Co. Ltd
• AstaSupreme
• BGG (Beijing Ginko Group)
• Holland & Barrett Retail Limited
• JXTG群組
• KeyNatura
• Koninklijke Dsm NV
• Piveg Inc.
• Valensa International

第8章 附錄

• 免責聲明

The global inositol market is projected to grow at a CAGR of 8.23% during the forecast period (2020-2025).

Key Highlights

• Inositol is a naturally occurring nutrient that is usually classified as a carbocyclic polyol. The most common form is sometimes referred to as myo-inositol. In the human body, it plays a major role in preventing the collection of fats in the liver, as well as promoting healthy hair growth.
• The growing number of people affected by diseases like PCOS, diabetes. and others, due to the adoption of poor lifestyle and increased consumption of junk food, is leading to a rise in the demand for drugs and supplements containing inositol, owing to its many curing properties as it is a member of the vitamin B complex.

Key Market Trends

Increasing Demand from Inositol in Pharmaceutical Industry

Increasing demand for products with inositol content among women suffering from polycystic ovarian syndrome is a major factor expected to drive the growth of the global inositol market. Moreover, increasing demand from the pharmaceutical sector for medicine preparation that aids in the treatment of neonatal respiratory distress syndrome in infants is another factor expected to witness a significant growth of the market during the forecast period. Furthermore, manufacturer's and researchers' approach towards increasing the use of inositol in cancer medicine preparation is another factor expected to further support the growth of the market during the forecast period.

North America Dominates the Global Market

North America is expected to continue registering significant demand for inositol during the forecast period. High prevalence of polycystic ovary syndrome, digestive disorders, and lifestyle-related diseases on account of the poor eating habits and high consumption of processed food, is expected to drive the demand for inositol supplements. The market in the Asia Pacific is expected to witness significant growth, owing to the growing pharmaceutical sector and increasing government spending on the healthcare sector. Also, the presence of regional players operating in the countries offering innovative products is expected to further boost the growth of the market in this region. Europe is expected to contribute significant revenue share in the global market.

Competitive Landscape

Major players are in the inositol market like Taiho Pharmaceutical Co. Ltd launched Tiovita Drink Aibitasu Zero (third-class OTC drug), caffeine-free, sugar-free product containing 50g of inositol, under its Tiovita range, in Japan.Some of the major key players in inositol market, globally includes Dsm NV, Charles Bowman & Company, T.J. Clark & Company, Shandong Runde Biotechnology Co, among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Drivers
• 4.2 Market Restraints
• 4.3 Porter's Five Force Analysis
  • 4.3.1 Threat of New Entrants
  • 4.3.2 Bargaining Power of Buyers/Consumers
  • 4.3.3 Bargaining Power of Suppliers
  • 4.3.4 Threat of Substitute Products
  • 4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Source
  • 5.1.1 Plant Based Inositol
  • 5.1.2 Synthetic Inositol
• 5.2 By Application
  • 5.2.1 Dietary Supplement
  • 5.2.2 Beverage
  • 5.2.3 Feed Industry
  • 5.2.4 Pharmaceutical Industry
  • 5.2.5 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.1.4 Rest of North America
  • 5.3.2 Europe
    • 5.3.2.1 United Kingdom
    • 5.3.2.2 Germany
    • 5.3.2.3 France
    • 5.3.2.4 Russia
    • 5.3.2.5 Italy
    • 5.3.2.6 Spain
    • 5.3.2.7 Rest of Europe
  • 5.3.3 Asia Pacific
    • 5.3.3.1 India
    • 5.3.3.2 China
    • 5.3.3.3 Japan
    • 5.3.3.4 Australia
    • 5.3.3.5 Rest of Asia-Pacific
  • 5.3.4 South America
    • 5.3.4.1 Brazil
    • 5.3.4.2 Argentina
    • 5.3.4.3 Rest of South America
  • 5.3.5 Middle East & Africa
    • 5.3.5.1 South Africa
    • 5.3.5.2 Saudi Arabia
    • 5.3.5.3 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Most Active Companies
• 6.2 Most Adopted Strategies
• 6.3 Market Share Analysis
• 6.4 Company Profiles
  • 6.4.1 Koninklijke DSM N.V
  • 6.4.2 Holland & Barrett Retail Limited
  • 6.4.3 Changzhou Zhonglian Inositol Co.
  • 6.4.4 Zhucheng Haotian Pharm Co., Ltd
  • 6.4.5 Shandong Runde Biotechnology Co
  • 6.4.6 Mr. Bill's Pipe & Tobacco Company
  • 6.4.7 Charles Bowman & Company
  • 6.4.8 T.J. Clark & Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS